Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 -14.74%
March 31, 2026 -14.81%
December 31, 2025 -18.07%
September 30, 2025 -104.6%
June 30, 2025 -41.52%
March 31, 2025 -1.83%
December 31, 2024 -21.66%
September 30, 2024 -2.74%
June 30, 2024 -23.21%
March 31, 2024 -240.4%
December 31, 2023 0.94%
September 30, 2023 -1.71%
June 30, 2023 -8.02%
March 31, 2023 5.77%
December 31, 2022 3.51%
September 30, 2022 2.45%
June 30, 2022 3.15%
March 31, 2022 47.89%
December 31, 2021 45.74%
September 30, 2021 42.33%
June 30, 2021 10.80%
March 31, 2021 47.45%
December 31, 2020 58.10%
September 30, 2020 48.79%
June 30, 2020 33.53%
Date Value
March 31, 2020 23.04%
December 31, 2019 20.13%
September 30, 2019 12.79%
June 30, 2019 1.17%
March 31, 2019 16.79%
December 31, 2018 24.50%
September 30, 2018 9.22%
June 30, 2018 -2.98%
March 31, 2018 20.08%
December 31, 2017 -4.43%
September 30, 2017 -10.86%
June 30, 2017 -30.95%
March 31, 2017 19.39%
December 31, 2016 -3.69%
September 30, 2016 -1.16%
June 30, 2016 -20.03%
March 31, 2016 -6.85%
December 31, 2015 -0.72%
September 30, 2015 -1.63%
June 30, 2015 -25.61%
March 31, 2015 6.51%
December 31, 2014 11.18%
September 30, 2014 -14.12%
June 30, 2014 -21.94%
March 31, 2014 -3.24%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 27.82%
Neogen Corp. -5.34%
Aspira Women's Health, Inc. -118.3%
VolitionRX Ltd. -1.95K%
Lucid Diagnostics, Inc. -792.9%